Literature DB >> 18083926

A novel transgenic mouse model to study the osteoblast lineage in vivo.

Christa Maes1, Tatsuya Kobayashi, Henry M Kronenberg.   

Abstract

Over the past few decades, osteoblast differentiation has been studied extensively in a variety of culture systems and findings from these experiments have shaped our understanding of the bone-forming cell lineage. However, in vitro assays are bound by intrinsic limitations and are unable to effectively mirror many aspects related to osteoblasts in vivo, including their origin, destiny, and life span. Therefore, these fundamental questions strongly advocate the need for novel models to characterize the osteoblast lineage in vivo. Here, we developed a transgenic mouse system to study stage-specific subsets of osteoblast lineage cells. We believe that this system will prove to be a helpful tool in deciphering multiple aspects of osteoblast biology in vivo.

Entities:  

Mesh:

Year:  2007        PMID: 18083926     DOI: 10.1196/annals.1402.060

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  34 in total

1.  Localized all-cell knock-out (LACKO) strategy is needed for studying adult stage diseases.

Authors:  Xiaolan Du; Ying Zhu; Fengtao Luo; Lin Chen
Journal:  Transgenic Res       Date:  2012-06-14       Impact factor: 2.788

Review 2.  Autocrine and Paracrine Actions of IGF-I Signaling in Skeletal Development.

Authors:  Yongmei Wang; Daniel D Bikle; Wenhan Chang
Journal:  Bone Res       Date:  2013-09-25       Impact factor: 13.567

3.  Identification of a clonally expanding haematopoietic compartment in bone marrow.

Authors:  Lin Wang; Rui Benedito; M Gabriele Bixel; Dagmar Zeuschner; Martin Stehling; Lars Sävendahl; Jody J Haigh; Hugo Snippert; Hans Clevers; Georg Breier; Friedemann Kiefer; Ralf H Adams
Journal:  EMBO J       Date:  2012-11-27       Impact factor: 11.598

4.  Hypoxia, HIFs and bone development.

Authors:  Elisa Araldi; Ernestina Schipani
Journal:  Bone       Date:  2010-05-02       Impact factor: 4.398

5.  Loss-of-function of ACVR1 in osteoblasts increases bone mass and activates canonical Wnt signaling through suppression of Wnt inhibitors SOST and DKK1.

Authors:  Nobuhiro Kamiya; Vesa M Kaartinen; Yuji Mishina
Journal:  Biochem Biophys Res Commun       Date:  2011-09-17       Impact factor: 3.575

Review 6.  Aging of the hematopoietic stem cells niche.

Authors:  Ayako Nakamura-Ishizu; Toshio Suda
Journal:  Int J Hematol       Date:  2014-08-06       Impact factor: 2.490

7.  A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes.

Authors:  Kevin B Jones; Virginia Piombo; Charles Searby; Gail Kurriger; Baoli Yang; Florian Grabellus; Peter J Roughley; Jose A Morcuende; Joseph A Buckwalter; Mario R Capecchi; Andrea Vortkamp; Val C Sheffield
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

8.  YAP and TAZ Promote Periosteal Osteoblast Precursor Expansion and Differentiation for Fracture Repair.

Authors:  Christopher D Kegelman; Madhura P Nijsure; Yasaman Moharrer; Hope B Pearson; James H Dawahare; Kelsey M Jordan; Ling Qin; Joel D Boerckel
Journal:  J Bone Miner Res       Date:  2020-10-07       Impact factor: 6.741

Review 9.  Prospects for osteoprogenitor stem cells in fracture repair and osteoporosis.

Authors:  Gregory A Clines
Journal:  Curr Opin Organ Transplant       Date:  2010-02       Impact factor: 2.640

10.  Snail1 controls bone mass by regulating Runx2 and VDR expression during osteoblast differentiation.

Authors:  Cristina A de Frutos; Romain Dacquin; Sonia Vega; Pierre Jurdic; Irma Machuca-Gayet; M Angela Nieto
Journal:  EMBO J       Date:  2009-02-05       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.